Evidence map›Paper›PMID 28401415›Full record

ArticleAIDS and behavior2017

Monitoring HIV Treatment and the Health Sector Cascade: From Treatment Numbers to Impact.

Daniel Low-Beer, Michel Beusenberg, Chika Hayashi, Txema Calleja, Kimberly Marsh, Awandha Mamahit, Theresa Babovic, Gottfried Hirnschall

Abstract read
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel Low-BeerHIV Department, WHO, Geneva, Switzerland. LowBeerd@who.int.ORCID http://orcid.org/0000-0003-0042-0518
Michel BeusenbergHIV Department, WHO, Geneva, Switzerland.
Chika HayashiHIV Department, WHO, Geneva, Switzerland.
Txema CallejaHIV Department, WHO, Geneva, Switzerland.
Kimberly MarshUNAIDS, Geneva, Switzerland.
Awandha MamahitHIV Department, WHO, Geneva, Switzerland.
Theresa BabovicHIV Department, WHO, Geneva, Switzerland.
Gottfried HirnschallHIV Department, WHO, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Although not originally part of the MDGs, HIV treatment has been at the center of global HIV reporting since 2003, marked by achievement of the target of 15 million people receiving treatment before 2015 and 18.2 million (16.1-19.0 million) by mid 2016. Monitoring of treatment has been strengthened with harmonized partner reporting and accountability with regular, annual reports. Beyond treatment numbers, increasingly measures of treatment adherence, retention and outcomes have been reported though with varying quality and completeness. However, with the sustainable development goals (SDGs), monitoring treatment is changing in three important ways. First, treatment monitoring is shifting from numbers to coverage and gaps in a cascade of services to achieve universal access. Secondly, this requires greater emphasis on disaggregated, individual level patient and case monitoring systems, which can better support linkage, retention and chronic, long term care. Thirdly, the prevention, testing and treatment cascade with a clear results chain, links treatment numbers to impact, in terms of reduced viral load, mortality and incidence. This agenda will require a greater contribution of routine impact evaluation alongside monitoring, with treatment seen as part of a cascade of services to ensure impact on mortality and incidence. In conclusion, the shift from monitoring treatment numbers to treatment linked to universal access to prevention, testing and treatment and impact on mortality and incidence, will be critical to monitor, evaluate, and improve HIV programs as part of the SDGs.

Indexed as

Program EvaluationAnti-HIV AgentsCommunicable Disease ControlGovernment ProgramsHealth Services AccessibilityHIV InfectionsHumansIncidenceNational Health ProgramsPopulation SurveillancePublic HealthTreatment OutcomeAnti-HIV AgentsHealth sector cascadeHIVImpactProgram improvementSustainable development goalsTreatment

Identifiers

PMID28401415
PMCPMC5515963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.